-
公开(公告)号:AU2009269127A1
公开(公告)日:2010-01-14
申请号:AU2009269127
申请日:2009-08-06
Applicant: ACADEMIA SINICA
Inventor: YU ALICE , WONG CHI-HUEY , WU CHUNG-YI , YU JOHN
IPC: A61K39/00 , A61K39/385
Abstract: An immunogenic composition containing a glycan conjugate including a carrier protein, and a glycan including Globo H, an immunogenic fragment thereof, or stage-specific embryonic antigen-4 (SSEA-4), wherein the glycan is conjugated with the carrier protein through a linker.
-
公开(公告)号:AU2025201644A1
公开(公告)日:2025-03-27
申请号:AU2025201644
申请日:2025-03-06
Applicant: ACADEMIA SINICA
Inventor: LIAO HSIN-YU , WANG SHIH-CHI , KO YI-AN , LIN KUO-I , MA CHE , CHENG TING-JEN , WONG CHI-HUEY
IPC: A61K39/145 , A61P31/16 , C12N7/04
Abstract: Abstract The present disclosure relates to a chimeric influenza virus hemagglutinin (HA) polypeptide, comprising one or more stem domain sequence, each having at least 60% homology with a stem domain consensus sequence of HI subtype HA (HI HA) and/or H5 subtype HA (H5 HA), fused with one or more globular head domain sequences, each having at least 60% homology with a globular head domain consensus sequence of HI subtype HA (HI HA) or H5 subtype HA (H5 HA).
-
公开(公告)号:CA2870335C
公开(公告)日:2022-05-03
申请号:CA2870335
申请日:2013-04-12
Applicant: ACADEMIA SINICA , WONG CHI HUEY , FANG JIM MIN , LIU KUNG CHENG , JAN JIA TSRONG , CHENG YIH SHYUN E , CHENG TING JEN R
Inventor: WONG CHI-HUEY , FANG JIM-MIN , LIU KUNG-CHENG , JAN JIA-TSRONG , CHENG YIH-SHYUN E , CHENG TING-JEN R
IPC: C07D309/28 , A61K31/195 , A61K31/215 , A61K31/351 , A61K31/662 , A61P29/00 , A61P31/16 , C07C229/64 , C07C279/16 , C07D407/12 , C07F9/655
Abstract: Novel dual-targeted, bifunctional anti-influenza drugs formed by conjugation with anti-inflammatory agents are disclosed. Exemplary drugs according to the invention include caffeic acid (CA)-bearing zanamivir (ZA) conjugates ZA-7-CA (1), ZA-7-CA-amide (7) and ZA-7-Nap (43) for simultaneous inhibition of influenza virus neuraminidase and suppression of proinflammatory cytokines. Synthetic methods for preparation of these enhanced anti- influenza conjugate drugs are provided. The synthetic bifunctional ZA conjugates act synergistically towards protection of mice lethally infected by H1N1 or H5N1 influenza viruses. The efficacy of ZA-7-CA, ZA-7-CA-amide and ZA-7-Nap conjugates is much greater than the combination therapy of ZA with anti-inflammatory agents.
-
公开(公告)号:AU2015267051B2
公开(公告)日:2022-03-17
申请号:AU2015267051
申请日:2015-05-27
Applicant: ACADEMIA SINICA
Inventor: WONG CHI-HUEY , TSAI TSUNG-I
IPC: C12N9/24
Abstract: The present disclosure relates to an a-fucosidase having a-(1,2), a-(1,3), a-(1,4), and a-(1,6) fucosidase activity. The present disclosure also relates to the compositions comprising the α-fucosidase, and the methods of producing and using the α-fucosidase in cleaving a-(1,2), a-(1,3), a-(1,4), and/or a-(1,6)-linked fucoses in the glycoconjugates. Accordingly, the present invention provides the compositions and methods for the improved enzymatic hydrolysis of fucose in vitro. In particular, the present invention is useful for the efficient cleavage of core fucose in native glycoproteins without denaturation or functional deterioration of glycoproteins. The compositions and methods of the invention can facilitate the Fc glycoengineering of Fc fusion proteins or antibodies, such as therapeutic antibodies.
-
135.
公开(公告)号:CA2854619C
公开(公告)日:2022-02-01
申请号:CA2854619
申请日:2011-11-04
Applicant: ACADEMIA SINICA
Inventor: WONG CHI-HUEY , MA CHE , TSENG YUNG-CHIEH
Abstract: Methods for production of virus particles with simplified glycosylation on structural or surface proteins are provided. When used as targets for vaccine production, the conserved nature of such sites generates vaccines that are less sensitive to viral mutations. Use of glycosylation inhibitors for production of viruses with simplified glycosylation profiles are disclosed. An exemplary disclosure of influenza viruses and methods for production of mono-glycosylated influenza virus particles is provided. Methods for production of mono-glycosylated forms of influenza A virus, NIBRG-14 (H5N1) are provided.
-
136.
公开(公告)号:DK3250590T3
公开(公告)日:2021-10-18
申请号:DK16744256
申请日:2016-01-30
Applicant: ACADEMIA SINICA
Inventor: WONG CHI-HUEY , MA CHE , WU HAN-CHUNG , WU CHUNG-YI
-
137.
公开(公告)号:AU2016211176B2
公开(公告)日:2021-01-28
申请号:AU2016211176
申请日:2016-01-30
Applicant: ACADEMIA SINICA
Inventor: WONG CHI-HUEY , WU CHUNG-YI , MA CHE , WU HAN-CHUNG
Abstract: The present disclosure relates to compositions and methods of use comprising antibodies or binding fragments thereof further comprising universal Fc glycoforms.
-
公开(公告)号:CA3131096A1
公开(公告)日:2020-10-08
申请号:CA3131096
申请日:2020-03-10
Applicant: ACADEMIA SINICA
Inventor: WONG CHI-HUEY , LO HONG-JAY
Abstract: Disclosed are a method of preparing a saccharide that contains a 3-fluoro-sialic acid and a method of bonding it to a homogeneous antibody. Also within the scope of this invention are compounds each containing a 3-fluoro-sialic acid, monoclonal antibodies bonded to ?2,6-linked 3-fluoro-sialoside terminated N-glycans, and treatment of cancer with such monoclonal antibodies.
-
公开(公告)号:AU2019203313B2
公开(公告)日:2020-04-30
申请号:AU2019203313
申请日:2019-05-10
Applicant: ACADEMIA SINICA
Inventor: WONG CHI-HUEY , WU CHUNG-YI , TSAI TSUNG-I
Abstract: Abstract A novel UDP-Gal regeneration process and its combined use with a galactosyltransferease to add galactose to a suitable acceptor substrate. Also described herein are synthetic methods for generating Globo-series oligosaccharides in large scale, wherein the methods may involve the combination of a glycosyltransferase reaction and a nucleotide sugar regeneration process.
-
公开(公告)号:AU2018200094B2
公开(公告)日:2019-02-14
申请号:AU2018200094
申请日:2018-01-05
Applicant: ACADEMIA SINICA
Inventor: WONG CHI-HUEY , WU CHUNG-YI , TSAI TSUNG-I
Abstract: Abstract A novel UDP-Gal regeneration process and its combined use with a galactosyltransferease to add galactose to a suitable acceptor substrate. Also described herein are synthetic methods for generating Globo-series oligosaccharides in large scale, wherein the methods may involve the combination of a glycosyltransferase reaction and a nucleotide sugar regeneration process.
-
-
-
-
-
-
-
-
-